Hemp-derived CBD oil products will not get you “high” since they contain little or no THC, the psychoactive ingredient in cannabis. They are also now federally legal in the United States following the signing of the 2018 Farm Bill. Of course more medical research studies are needed, but it’s expected that these products will continue to gain even more mainstream acceptance in the plant-based wellness communities.
Hemp is completely different from marijuana in its function, cultivation and application. But these differences didn’t stop our political leaders from getting confused and accidentally grouping all Cannabis species as a Schedule I Drug and banning it in 1970 under the Controlled Substances Act. Even after 45 years, the government still seems to have some confusion in distinguishing the two plants. Although legislation is being made, progress has been slow.In its application, hemp and marijuana serve completely different purposes. Marijuana, as it is widely known, is used for medicinal or recreational purposes. Hemp is used in variety of other applications that marijuana couldn’t possibly be used in. These include healthy dietary supplements, skin products, clothing, and accessories. Overall, hemp is known to have over 25,000 possible applications.
Millennia of selective breeding have resulted in varieties that display a wide range of traits; e.g. suited for a particular environments/latitudes, producing different ratios and compositions of terpenoids and cannabinoids (CBD, THC, CBG, CBC, CBN...etc.), fibre quality, oil/seed yield, etc. Hemp grown for fiber is planted closely, resulting in tall, slender plants with long fibers.
Generally speaking, ingesting CBD oils using a dropper is typically the easiest way to stay in control of exactly how much you are taking. Plus, pure CBD oil will not contain additives that come with side effects. Remember, when you are using CBD oil or any kind of cannabis product, you must read the product label to determine the best dose for you.
The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug and Cosmetic Act requires this notice.
Those who are looking for a unique and high-end form of cannabidiol products may want to look into Lord Jones. The products come in the form of tinctures, edibles, lotion, and even gumdrops. The formulas are also designed to provide users with relief from aches, pains, stress, and so much more. Better yet, the products come in unique and tantalizing flavors, including mango chili and sugarplum.
These products are not FDA approved and we are not claiming that this oil can cure or treat any of the conditions mentioned above or on this website. The US government owns the patent on CBD, patent #6630507. This patent is not new, in fact it was applied for in 1999 and granted in 2003 to the US Department of Health and Human Services. To read a quick summary on what this patent contains please click on the link below.
The world-leading producer of hemp is China, which produces more than 70% of the world output. France ranks second with about a quarter of the world production. Smaller production occurs in the rest of Europe, Chile, and North Korea. Over 30 countries produce industrial hemp, including Australia, Austria, Canada, Chile, China, Denmark, Egypt, Finland, Germany, Greece, Hungary, India, Italy, Japan, Korea, Netherlands, New Zealand, Poland, Portugal, Romania, Russia, Slovenia, Spain, Sweden, Switzerland, Thailand, Turkey, the United Kingdom and Ukraine.
Zuardi, A. W., Crippa, J. A., Hallak, J. E., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., … & Guimarães, F. S. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Abstract]. Current Pharmaceutical Design, 18(32), 5,131–5,140. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22716160